|
US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な1,2,4−オキサジアゾ−ル誘導体
|
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EP1582519A3
(de)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren
|
|
CN1313465C
(zh)
*
|
1999-08-19 |
2007-05-02 |
Nps药物有限公司 |
杂多环化合物及其用于制备代谢性谷氨酸受体拮抗剂的应用
|
|
CA2438991C
(en)
*
|
2001-02-21 |
2010-08-17 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2004014902A2
(en)
*
|
2002-08-09 |
2004-02-19 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
|
CA2520255C
(en)
*
|
2003-04-09 |
2014-07-08 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
|
CA2524867A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
|
BRPI0418149A
(pt)
*
|
2003-12-24 |
2007-04-17 |
Prosidion Ltd |
derivados heterocìclicos como agonistas do receptor de gprc
|
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
WO2006114400A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Neurosearch A/S |
Novel oxadiazole derivatives and their medical use
|
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
|
AU2006272978B2
(en)
|
2005-07-26 |
2012-06-07 |
Bial - Portela & Ca, S.A. |
Nitrocatechol derivatives as COMT inhibitors
|
|
EP1845097A1
(de)
*
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazolderivate als COMT Inihibitoren
|
|
CL2007002593A1
(es)
*
|
2006-09-07 |
2008-06-13 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de 4-heteroaril-piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como rechazo de organos transplantados, sindromes autoinmunes y cancer.
|
|
SI2069335T1
(sl)
*
|
2006-09-08 |
2013-04-30 |
Actelion Pharmaceuticals Ltd. |
Derivati piridin-3-ila kot imunomodulacijska sredstva
|
|
CN101631548B
(zh)
*
|
2007-01-31 |
2014-08-27 |
比艾尔-坡特拉有限公司 |
Comt抑制剂的单次药物剂量单元和药物组合物
|
|
JP2010521450A
(ja)
*
|
2007-03-16 |
2010-06-24 |
アクテリオン ファーマシューティカルズ リミテッド |
S1p1/edg1受容体アゴニストとしてのアミノ−ピリジン誘導体
|
|
PL2195311T3
(pl)
*
|
2007-08-17 |
2011-08-31 |
Actelion Pharmaceuticals Ltd |
Pochodne pirydynowe jako modulatory receptora S1P1/EDG1
|
|
EP2259777A2
(de)
*
|
2008-02-28 |
2010-12-15 |
BIAL - Portela & Ca., S.A. |
Pharmazeutische zusammensetzung für schwer lösliche arzneimittel
|
|
EP2262799B1
(de)
*
|
2008-03-06 |
2012-07-04 |
Actelion Pharmaceuticals Ltd. |
Pyridinverbindungen
|
|
SI2252609T1
(sl)
*
|
2008-03-07 |
2013-07-31 |
Actelion Pharmaceuticals Ltd. |
Derivati piridin-2-ila kot imunomodulacijska sredstva
|
|
AU2009226221A1
(en)
|
2008-03-17 |
2009-09-24 |
Bial - Portela & Ca., S.A. |
Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol
|
|
HUE025984T2
(hu)
*
|
2008-05-14 |
2016-05-30 |
Scripps Research Inst |
Szfingozin foszfát receptor új modulátorai
|
|
HUE025314T2
(en)
|
2009-02-10 |
2016-02-29 |
Monsanto Technology Llc |
Preparations and procedures for controlling nematodes
|
|
KR102023255B1
(ko)
*
|
2009-04-01 |
2019-09-19 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
|
|
JP5864410B2
(ja)
*
|
2009-04-01 |
2016-02-17 |
ノヴィファーマ ソシエテ アノニム |
ニトロカテコール誘導体を含む医薬製剤及びその製造方法
|
|
KR101409131B1
(ko)
|
2009-07-16 |
2014-06-17 |
액테리온 파마슈티칼 리미티드 |
피리딘-4-일 유도체
|
|
SG191742A1
(en)
|
2011-01-19 |
2013-08-30 |
Actelion Pharmaceuticals Ltd |
2-methoxy-pyridin-4-yl derivatives
|
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
|
BR112014014341A2
(pt)
|
2011-12-13 |
2017-08-22 |
Bial Portela & Ca Sa |
Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica
|
|
UY35327A
(es)
|
2013-02-15 |
2014-09-30 |
Monsanto Technology Llc |
?4,5-dihidro-1,2,4-oxadiazoles disustituidos en 3,5 y composiciones y métodos para controlar plagas de nematodos?.
|
|
WO2016083863A1
(en)
|
2014-11-28 |
2016-06-02 |
Bial - Portela & Ca, S.A. |
Medicaments for slowing parkinson's disease
|
|
MY192358A
(en)
|
2015-05-20 |
2022-08-17 |
Idorsia Pharmaceuticals Ltd |
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
|